MacroGenics Inc
NASDAQ:MGNX

Watchlist Manager
MacroGenics Inc Logo
MacroGenics Inc
NASDAQ:MGNX
Watchlist
Price: 1.715 USD -2.56% Market Closed
Market Cap: $108.5m

Wall Street
Price Targets

MGNX Price Targets Summary
MacroGenics Inc

Wall Street analysts forecast MGNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MGNX is 3.468 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

Lowest
Price Target
2.02 USD
18% Upside
Average
Price Target
3.468 USD
102% Upside
Highest
Price Target
5.25 USD
206% Upside
MacroGenics Inc Competitors:
Price Targets
AXSM
Axsome Therapeutics Inc
11% Upside
ANY
ANY Biztonsagi Nyomda Nyrt
-14% Downside
AMSF
Amerisafe Inc
36% Upside
NN
NextNav Inc
18% Upside

Revenue
Forecast

7% / Year
Past Growth
-15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
7% / Year
Past Growth
-15% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

For the last 12 years the compound annual growth rate for MacroGenics Inc's revenue is 7%. The projected CAGR for the next 4 years is -15%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MGNX's stock price target?
Price Target
3.468 USD

According to Wall Street analysts, the average 1-year price target for MGNX is 3.468 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

What is MacroGenics Inc's Revenue forecast?
Projected CAGR
-15%

For the last 12 years the compound annual growth rate for MacroGenics Inc's revenue is 7%. The projected CAGR for the next 4 years is -15%.

Back to Top